Sanofi-aventis Announces 2007 Earnings Ahead of Guidance Sharp Rise in Propose...(Adjuvant Trial 9735 at the 2007 San Anto...),Health

Breast Cancer Symposium, showing that

Taxotere(R) and cyclophosphamide improved

overall survival versus an anthracycline

combination

January 3, 2008 Announcement of the signature of an

agreement between sanofi pasteur and Crucell

for a next-generation rabies vaccine

January 28, 2008 Announcement of approval for marketing in

Japan of Lovenox(R) for the prevention of

venous thrombo-embolism in patients

undergoing orthopedic surgery of the lower

limbs such as total hip replacement, total

knee replacement and hip fracture surgery

Financial Timetable

April 30, 2008 2008 first-quarter net sales and results

May 14, 2008 Shareholders' Annual General Meeting

July 31, 2008 2008 second-quarter net sales and results

October 31, 2008 2008 third-quarter net sales and results

Appendices

List of appendices

Appendix 1: Explanatory Notes/Financial Indicators

Appendix 2: 2007 fourth-quarter, full-year, first-quarter, second-quarter

and third-quarter net sales by product

Appendix 3: 2007 fourth-quarter and full-year adjusted consolidated

income statements

Appendix 4: 2007 fourth-quarter and full-year reconciliation of

consolidated income statement to adjusted consolidated income

statement

Appendix 5: Simplified consolidated statement of cash flows and

consolidated balance sheet

Appendix 6: Trends in selected items in the adjusted income statement

Appendix 1: Explanat
'/>"/>